Streetbeat News

Stock Prices

ENTA

Enanta Pharmaceuticals will be replaced in the S&P SmallCap 600, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 5:04 pm

SYK

Shares of Stryker Corp (NYSE:SYK) continued to rise after ending last week with gains. BofA Securities is optimistic about the company's margins and sees an opportunity for upside in 2024. Analyst Travis Steed upgraded Stryker from Neutral to Buy and raised the price target from $310 to $315. The company has several product launches planned which could boost its revenue growth by 100-200 basis points.

Portfolio Pulse from Priya Nigam

September 05, 2023 | 5:03 pm

CABA

Citigroup has initiated coverage on Cabaletta Bio with a Buy rating and a price target of $22. This has led to an increase in the trading of Cabaletta Bio shares.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 5:01 pm

OLMA

Olema Pharmaceuticals has announced a private placement and a senior-secured credit facility for combined financing of up to $180 million. This has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 5:01 pm

TSE

Trinseo, a global materials company, will be replaced in the S&P SmallCap 600, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 5:01 pm

DIS

Analysts have provided various ratings for Walt Disney (NYSE:DIS) within the last quarter, with a majority being bullish. The average price target for Walt Disney over the next 12 months is $113.54, a decrease of 8.97% from the previous average price target of $124.73.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 5:00 pm

MODN

Model N (NYSE:MODN) has received a mix of bullish and indifferent ratings from analysts in the last quarter. The average price target is $41.38, implying an upside from the current price of $26.745. However, this average has decreased by 8.04% from the previous target of $45.00.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 5:00 pm

DKNG

Over the past 3 months, 33 analysts have published their opinion on DraftKings (NASDAQ:DKNG) stock. The average price target for DraftKings has increased by 15.29% from the previous average price target of $29.36 to $33.85. The high and low price targets are $44.00 and $20.00 respectively.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 5:00 pm

MDB

Argus Research has maintained its Buy rating for MongoDB (NASDAQ:MDB) and increased its price target from $435.00 to $484.00. This new target price represents a 23.0% increase from the current share price. MongoDB's shares have seen a 0.16% increase over the last 24 hours.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 5:00 pm

OLMA

Over the past 3 months, 5 analysts have published their opinion on Olema Pharmaceuticals (NASDAQ:OLMA) stock. The current average price target for the stock has increased by 21.74% from the previous average price target of $17.25 to $21.0. The analysts are generally bullish on the stock.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 5:00 pm